Skip to main content

Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis.

Publication ,  Journal Article
Kirk, AD; Heisey, DM; D'Alessandro, AM; Knechtle, SJ; Odorico, JS; Rayhill, SC; Sollinger, HW; Pirsch, JD
Published in: Transplantation
December 27, 1996

BACKGROUND: Exposure to hepatitis C virus (HCV) and subsequent infection after renal transplantation lead to significant clinical hepatitis in approximately 50% of graft recipients. METHODS: One hundred thirty-two consecutive renal allotransplant patients, who underwent transplantation of kidneys from HCV-positive cadaveric donors, were studied to investigate the relationship between donor and recipient HLA type and the risk of developing clinical hepatitis. Specific attention was directed toward the DR3 and DR4 alleles, as these had previously been associated with worse prognoses in autoimmune and viral hepatitis. RESULTS: Overall, 42% of patients receiving kidneys from donors seropositive for HCV developed clinical hepatitis. This was unrelated to preoperative recipient HCV serum reactivity (P=0.65). Patients receiving kidneys from seropositive donors with HCV RNA as detected by PCR were more likely to develop hepatitis than those receiving kidneys from PCR-negative donors (56% vs. 11%; P=0.005). The presence of the DR3 allele was associated with a significant risk of clinical hepatitis (P=0.025); 80% of DR3-positive recipients (n=34) progressed to hepatitis compared with 42% of DR3-negative patients. No other recipient HLA type was significantly related to prognosis. All patients receiving a donated kidney that expressed the B41 allele developed hepatitis, compared with 55% of recipients of non-B41 grafts (P=0.039). No association between the development of clinical hepatitis and HLA compatibility was found. CONCLUSIONS: These results suggest that both HLA type and viral presence as assayed by polymerase chain reaction, influence the risk of disease progression after transplantation of HCV-positive kidneys. Application of these associations may decrease the relative risk of a recipient contracting HCV hepatitis after cadaveric renal transplantation.

Duke Scholars

Published In

Transplantation

DOI

ISSN

0041-1337

Publication Date

December 27, 1996

Volume

62

Issue

12

Start / End Page

1758 / 1762

Location

United States

Related Subject Headings

  • Surgery
  • Risk Factors
  • Kidney Transplantation
  • Kidney
  • Humans
  • Hepatitis C
  • Hepatitis
  • Hepacivirus
  • HLA-DR5 Antigen
  • HLA-DR4 Antigen
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kirk, A. D., Heisey, D. M., D’Alessandro, A. M., Knechtle, S. J., Odorico, J. S., Rayhill, S. C., … Pirsch, J. D. (1996). Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis. Transplantation, 62(12), 1758–1762. https://doi.org/10.1097/00007890-199612270-00011
Kirk, A. D., D. M. Heisey, A. M. D’Alessandro, S. J. Knechtle, J. S. Odorico, S. C. Rayhill, H. W. Sollinger, and J. D. Pirsch. “Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis.Transplantation 62, no. 12 (December 27, 1996): 1758–62. https://doi.org/10.1097/00007890-199612270-00011.
Kirk AD, Heisey DM, D’Alessandro AM, Knechtle SJ, Odorico JS, Rayhill SC, et al. Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis. Transplantation. 1996 Dec 27;62(12):1758–62.
Kirk, A. D., et al. “Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis.Transplantation, vol. 62, no. 12, Dec. 1996, pp. 1758–62. Pubmed, doi:10.1097/00007890-199612270-00011.
Kirk AD, Heisey DM, D’Alessandro AM, Knechtle SJ, Odorico JS, Rayhill SC, Sollinger HW, Pirsch JD. Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis. Transplantation. 1996 Dec 27;62(12):1758–1762.

Published In

Transplantation

DOI

ISSN

0041-1337

Publication Date

December 27, 1996

Volume

62

Issue

12

Start / End Page

1758 / 1762

Location

United States

Related Subject Headings

  • Surgery
  • Risk Factors
  • Kidney Transplantation
  • Kidney
  • Humans
  • Hepatitis C
  • Hepatitis
  • Hepacivirus
  • HLA-DR5 Antigen
  • HLA-DR4 Antigen